SOAs

17/02/2020

Statement of Advice (SOA): bevacizumab (Avastin) 1824

17/02/2020

Statement of Advice (SOA): bevacizumab (Avastin) 3165

17/02/2020

Statement of Advice (SOA): bezlotoxumab (Zinplava) 3034

17/02/2020

Statement of Advice (SOA): bilastine (llaxten) 1068

17/02/2020

Statement of Advice (SOA): bimato prost timolol (Ganfort) 2370

17/02/2020

Statement of Advice (SOA): Apalutamide (Erleada) 2450

17/02/2020

Statement of Advice (SOA): bismuth metronidazolete tracycline (Pylera)1544

18/02/2020

Statement of Advice (SOA): brentuximab vedotin (Adcetris) 2074

18/02/2020

Statement of Advice (SOA): bosentan (Tracleer) 68

18/02/2020

Statement of Advice (SOA): bosentan (Tracleer) 67

18/02/2020

Statement of Advice (SOA): bosutinib (Bosulif) 2507

18/02/2020

Statement of Advice (SOA): botulinum toxin type A (Botox) 2540

18/02/2020

Statement of Advice (SOA): botulinum toxin type A (Botox) 1845

18/02/2020

Statement of Advice (SOA): Brentuximab vedotin (Adcetris) 2074

18/02/2020

Statement of Advice (SOA): brexpiprazole (Rexulti) 1372

18/02/2020

Statement of Advice (SOA): bosentan (Tracleer) 68

12/02/2020

Statement of Advice (SOA): alendronic acid (Steovess) 1612

12/02/2020

Statement of Advice (SOA): allopurinol lesinurad (Duzallo) 3588

12/02/2020

Statement of Advice (SOA): alipogene tiparvovec (Glybera) 645

12/02/2020

Statement of Advice (SOA): alogliptin pioglitazone (Incresync) 1272